Strategic targeting of miR-183 and -catenin to enhance BMSC stemness in age-related osteoporosis therapy  Nature.com

See the rest here:

Strategic targeting of miR-183 and -catenin to enhance BMSC stemness in age-related osteoporosis therapy - Nature.com

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh